本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Ironwood医药

0.7660
+0.02633.56%
盘后0.7229-0.0431-5.63%15:19 EDT
成交量:102.71万
成交额:76.80万
市值:1.24亿
市盈率:-3.79
高:0.7660
开:0.7500
低:0.7301
收:0.7397
数据加载中...
2024/02/16

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/15

重要事件披露

Form 8-K - Current report
2024/02/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/10

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/08

重要事件披露

Form 8-K - Current report
2023/12/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/01

SEC问询函

Form CORRESP - Correspondence
2023/11/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/09

重要事件披露

Form 8-K - Current report
2023/11/09

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/11/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/09/11

重要事件披露

Form 8-K/A - Current report: [Amend]
2023/08/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/08

重要事件披露

Form 8-K - Current report
2023/08/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/07/07

超过5%披露

Form SC 13D - General statement of acquisition of beneficial ownership